Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Total Liabilities (Quarterly): 9.422B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.422B |
| June 30, 2024 | 9.422B |
| December 31, 2023 | 8.734B |
| June 30, 2023 | 8.120B |
| June 30, 2023 | 8.120B |
| December 31, 2022 | 7.217B |
| June 30, 2022 | 6.975B |
| June 30, 2022 | 6.975B |
| December 31, 2021 | 7.260B |
| June 30, 2021 | 8.492B |
| June 30, 2021 | 8.492B |
| December 31, 2020 | 8.636B |
| June 30, 2020 | 7.787B |
| June 30, 2020 | 7.787B |
| December 31, 2019 | 7.509B |
| June 30, 2019 | 7.418B |
| June 30, 2019 | 7.418B |
| December 31, 2018 | 7.751B |
| June 30, 2018 | 7.615B |
| June 30, 2018 | 7.615B |
| December 31, 2017 | 7.853B |
| June 30, 2017 | 4.479B |
| June 30, 2017 | 4.479B |
| Date | Value |
|---|---|
| December 31, 2016 | 4.474B |
| June 30, 2016 | 4.328B |
| June 30, 2016 | 4.328B |
| December 31, 2015 | 4.161B |
| June 30, 2015 | 4.409B |
| June 30, 2015 | 4.409B |
| December 31, 2014 | 4.360B |
| June 30, 2014 | 5.075B |
| June 30, 2014 | 5.075B |
| December 31, 2013 | 4.786B |
| June 30, 2013 | 5.138B |
| June 30, 2013 | 5.138B |
| December 31, 2012 | 5.411B |
| June 30, 2012 | 4.828B |
| June 30, 2012 | 4.828B |
| December 31, 2011 | 5.205B |
| June 30, 2011 | 2.717B |
| December 31, 2010 | 2.558B |
| June 30, 2010 | 2.352B |
| December 31, 2009 | 2.467B |
| June 30, 2009 | 2.780B |
| December 31, 2008 | 3.455B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.975B
Minimum
Jun 2022
9.422B
Maximum
Jun 2024
8.063B
Average
8.120B
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 126.94M |
| CRISPR Therapeutics AG | 358.90M |
| Addex Therapeutics Ltd | 1.164M |
| NLS Pharmaceutics Ltd | 10.46M |
| Molecular Partners AG | 16.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.89B |
| Shareholders Equity (Quarterly) | 10.40B |
| Debt to Equity Ratio | 0.4058 |
| Current Ratio | 2.042 |
| Net Debt Paydown Yield | -1.54% |